PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
The summary for the PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed): This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA. This Parent Funding Opportunity Announcement does not accept clinical trials.
Federal Grant Title: | PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education Environment Food and Nutrition Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-22-176 |
Type of Funding: | Grant |
CFDA Numbers: | 93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.142, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.326, 93.350, 93.351, 93.361, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | April 5th, 2023 |
Original Application Deadline: | April 5th, 2023 |
Posted Date: | June 2nd, 2022 |
Creation Date: | June 2nd, 2022 |
Archive Date: | May 11th, 2023 |
Total Program Funding: | |
Maximum Federal Grant Award: | $275,766 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | June 2nd, 2022 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-22-176.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations ...
- • PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...
- • Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determi...
- • PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...
- • PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...
- • Diabetes Prevention and Control in the Americas
- • Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease ...
- • Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth ...
- More Grants from the National Institutes of Health
- • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...
- • Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
- • NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
- • NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)